- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4745 - Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines
Patent holdings for IPC class A61K 31/4745
Total number of patents in this class: 3823
10-year publication summary
|
300
|
341
|
352
|
351
|
352
|
364
|
387
|
350
|
344
|
102
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1829 |
85 |
| Corcept Therapeutics, Inc. | 284 |
74 |
| Immunomedics, Inc. | 290 |
62 |
| Novartis AG | 11238 |
56 |
| Ipsen Biopharm Limited | 263 |
42 |
| The Regents of the University of California | 18943 |
34 |
| Neurocrine Biosciences, Inc. | 381 |
34 |
| Auspex Pharmaceuticals, Inc. | 205 |
32 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
29 |
| Merck Patent GmbH | 5909 |
28 |
| Purdue Research Foundation | 3277 |
28 |
| AstraZeneca AB | 3042 |
26 |
| Isofol Medical AB | 41 |
20 |
| Mitsubishi Gas Chemical Company, Inc. | 3188 |
20 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
19 |
| Birdie Biopharmaceuticals Inc. | 47 |
19 |
| California Institute of Technology | 3884 |
18 |
| Bristol-myers Squibb Company | 5080 |
17 |
| F. Hoffmann-La Roche AG | 7958 |
17 |
| Medicis Pharmaceutical Corporation | 100 |
17 |
| Other owners | 3146 |